A case of CD74‐ROS1‐positive lung adenocarcinoma diagnosed by next‐generation sequencing achieved long‐term survival with pemetrexed regimens

Previously, cytotoxic drugs were the only option for patients with non‐small cell lung cancer (NSCLC) and the prognosis was poor. However, molecularly targeted therapies and immune checkpoint inhibitors represent a breakthrough in the treatment of advanced NSCLC and have improved survival rates. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Satoshi, Yoshimura, Nobuaki, Asakawa, Ryo, Tobita, Satoshi, Yaga, Moto, Ueno, Kiyonobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481135/
https://www.ncbi.nlm.nih.gov/pubmed/37488715
http://dx.doi.org/10.1111/1759-7714.15041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481135/
https://www.ncbi.nlm.nih.gov/pubmed/37488715
http://dx.doi.org/10.1111/1759-7714.15041

Ejemplares similares